Home » FDA Clears Expanded Indications of Senhance Surgical System
FDA Clears Expanded Indications of Senhance Surgical System
Devices Submissions and Approvals
TransEnterix’s Senhance surgical system received 510(k) clearance for expanded indications, covering laparoscopic inguinal hernia and gall bladder surgery.
The device is a multiport surgical robotic system that has been used across a range of general surgery, upper gastrointestinal surgery and colorectal procedures.
It can be used for some of the most common abdominal surgeries, as well as procedures in general surgery and gynecology.